Araştırma Makalesi

ABO blood groups and hyperbaric oxygen therapy effectiveness in sudden hearing loss

Cilt: 2 Sayı: 2 29 Haziran 2021
PDF İndir
EN

ABO blood groups and hyperbaric oxygen therapy effectiveness in sudden hearing loss

Öz

Aim : The efficiency of hyperbaric oxygen (HBO) treatment according to ABO blood group system was evaluated in patients with Idiopathic sudden sensorineural hearing loss (ISSNHL). Methods: Serum lipid values and novel atherogenic risk calculations of 346 patients who came to the clinic for HBO treatment were performed. HBO treatment efficiency was evaluated on ABO blood groups. The effect of serum lipid levels and atherogenic risk levels on HBO treatment was measured according to the blood groups of ISSNHL patients. Results: The most important finding is that ISSNHL patients with O blood group antigen benefit the least from HBO therapy. Moreover, patients with O blood group antigen had statistically lower serum lipid values and atrogenic risk index than patients with non-O blood group. In addition, the frequency of O blood group in ISSNHL patients was higher than in non-O blood groups. Conclusions: The effect of serum lipid values and atherogenic risk indices in ISSNHL patients receiving HBO therapy may vary according to ABO blood groups. The relationship between hyperbaric oxygen therapy and the ABO blood grouping system should be supported by further research.

Anahtar Kelimeler

Destekleyen Kurum

yok

Kaynakça

  1. References: 1- Eren E, Yılmaz N, Koctekin B,Birinci S. High-density lipoprotein functionality and AB blood phenotype. Iraqi J Hematol 2020;9:66-71. oi: 10.4103/ijh.ijh_10_20
  2. 2-Yang Y, Hood LJ, McPherson B. Association between ABO blood group status and cochlear/neural function: auditory brainstem response findings. Acta Otolaryngol. 2021 Jan 11:1-6. doi: 10.1080/00016489.2020.1858236.
  3. 3- Birinci, S., Koctekin, B., Eren, E., Yilmaz, N. 2020. Lecithin- cholesterol acyltransferase and relationship with Platelet-activating factor in AB blood phenotype. Bali Medical Journal 9(1): 332-338. DOI: 10.15562/bmj.v9i1.1746
  4. 4- Rhee TM, Hwang D, Lee JS, Park J, Lee JM. Addition of Hyperbaric Oxygen Therapy vs Medical Therapy Alone for Idiopathic Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-analysis. JAMA Otolaryngol Head Neck Surg. 2018 Dec 1;144(12):1153-1161. doi: 10.1001/jamaoto.2018.2133.
  5. 5- Eren, E., Yıldırım, F., Giray, O., Yilmaz, N. (2019). Hyperbaric Oxygen Treatment is Associated with Lipid Inflammatory Response Assessed Using Serum Platelet Activating Factor, Polish Hyperbaric Research, 67(2), 103-108. doi: https://doi.org/10.2478/phr-2019-0009
  6. 6-Henderson D, Subramaniam M, Boettcher FA. Individual susceptibility to noise-induced hearing loss: an old topic revisited. Ear Hear. 1993 Jun;14(3):152-68. doi: 10.1097/00003446-199306000-00002. PMID: 8344472.
  7. 7-Quaranta N, Squeo V, Sangineto M, Graziano G, Sabbà C. High Total Cholesterol in Peripheral Blood Correlates with Poorer Hearing Recovery in Idiopathic Sudden Sensorineural Hearing Loss. PLoS One. 2015 Jul 24;10(7):e0133300. doi: 10.1371/journal.pone.0133300.
  8. 8- Byl FM Jr. Sudden hearing loss: eight years' experience and suggested prognostic table. Laryngoscope. 1984 May;94(5 Pt 1):647-61.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Klinik Tıp Bilimleri

Bölüm

Araştırma Makalesi

Yazarlar

Esin Eren
Türkiye

Furkan Yıldırım Bu kişi benim
0000-0003-3784-1236
Türkiye

Erken Görünüm Tarihi

16 Nisan 2024

Yayımlanma Tarihi

29 Haziran 2021

Gönderilme Tarihi

15 Mart 2021

Kabul Tarihi

28 Haziran 2021

Yayımlandığı Sayı

Yıl 2021 Cilt: 2 Sayı: 2

Kaynak Göster

APA
Eren, E., Yıldırım, F., Giray, O., & Yılmaz, N. (2021). ABO blood groups and hyperbaric oxygen therapy effectiveness in sudden hearing loss. Experimental and Applied Medical Science, 2(2), 176-183. https://izlik.org/JA43TR93WZ
AMA
1.Eren E, Yıldırım F, Giray O, Yılmaz N. ABO blood groups and hyperbaric oxygen therapy effectiveness in sudden hearing loss. Experimental and Applied Medical Science. 2021;2(2):176-183. https://izlik.org/JA43TR93WZ
Chicago
Eren, Esin, Furkan Yıldırım, Ozlem Giray, ve Necat Yılmaz. 2021. “ABO blood groups and hyperbaric oxygen therapy effectiveness in sudden hearing loss”. Experimental and Applied Medical Science 2 (2): 176-83. https://izlik.org/JA43TR93WZ.
EndNote
Eren E, Yıldırım F, Giray O, Yılmaz N (01 Haziran 2021) ABO blood groups and hyperbaric oxygen therapy effectiveness in sudden hearing loss. Experimental and Applied Medical Science 2 2 176–183.
IEEE
[1]E. Eren, F. Yıldırım, O. Giray, ve N. Yılmaz, “ABO blood groups and hyperbaric oxygen therapy effectiveness in sudden hearing loss”, Experimental and Applied Medical Science, c. 2, sy 2, ss. 176–183, Haz. 2021, [çevrimiçi]. Erişim adresi: https://izlik.org/JA43TR93WZ
ISNAD
Eren, Esin - Yıldırım, Furkan - Giray, Ozlem - Yılmaz, Necat. “ABO blood groups and hyperbaric oxygen therapy effectiveness in sudden hearing loss”. Experimental and Applied Medical Science 2/2 (01 Haziran 2021): 176-183. https://izlik.org/JA43TR93WZ.
JAMA
1.Eren E, Yıldırım F, Giray O, Yılmaz N. ABO blood groups and hyperbaric oxygen therapy effectiveness in sudden hearing loss. Experimental and Applied Medical Science. 2021;2:176–183.
MLA
Eren, Esin, vd. “ABO blood groups and hyperbaric oxygen therapy effectiveness in sudden hearing loss”. Experimental and Applied Medical Science, c. 2, sy 2, Haziran 2021, ss. 176-83, https://izlik.org/JA43TR93WZ.
Vancouver
1.Esin Eren, Furkan Yıldırım, Ozlem Giray, Necat Yılmaz. ABO blood groups and hyperbaric oxygen therapy effectiveness in sudden hearing loss. Experimental and Applied Medical Science [Internet]. 01 Haziran 2021;2(2):176-83. Erişim adresi: https://izlik.org/JA43TR93WZ